- Previous Close
0.171 - Open
0.172 - Bid 0.145 x --
- Ask 0.172 x --
- Day's Range
0.172 - 0.172 - 52 Week Range
0.116 - 2.060 - Volume
24,000 - Avg. Volume
26,427 - Market Cap (intraday)
11.455M - Beta (5Y Monthly) -0.45
- PE Ratio (TTM)
-- - EPS (TTM)
-0.270 - Earnings Date Mar 28, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
RMH Holdings Limited, an investment holding company, provides medical and dermatological aesthetic treatment and services in Singapore, Hong Kong, and the People's Republic of China. The company operates in two segments, Dental Services and Trading sales. It provides dermatology aesthetic and treatment, and dental care and dental implantation services. The company is involved in the treatment of skin cancer and skin diseases, such as eczema, psoriasis, acne, pigmentation, adverse drug reactions, and warts; and providing consultancy, prescription, and dispensing services. In addition, it engages in the trading of health and nutritional supplement products and medical products, including hand sanitizers, disposal medical masks, and other medical products; and offers orthodontics and implantology services. Further, the company operates franchised oral and dental clinics; and provides diagnostic and screening services, including computed tomography scanner, magnetic resonance imaging, ultrasounds, and mammography; and community dermatology services for less complicated dermatological conditions and non-invasive medical aesthetic treatments. RMH Holdings Limited was incorporated in 2017 and is headquartered in Singapore.
www.rmhholdings.com.sg45
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 8437.HK
View MorePerformance Overview: 8437.HK
Trailing total returns as of 4/9/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 8437.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 8437.HK
View MoreValuation Measures
Market Cap
11.46M
Enterprise Value
34.55M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.46
Price/Book (mrq)
--
Enterprise Value/Revenue
1.42
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-68.37%
Return on Assets (ttm)
-44.93%
Return on Equity (ttm)
--
Revenue (ttm)
5.13M
Net Income Avi to Common (ttm)
-3.51M
Diluted EPS (ttm)
-0.270
Balance Sheet and Cash Flow
Total Cash (mrq)
2.67M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--